Bio-Rad Laboratories EPS - Earnings per Share 2010-2022 | BIO.B

Bio-Rad Laboratories annual and quarterly earnings per share history from 2010 to 2022. Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
  • Bio-Rad Laboratories EPS for the quarter ending March 31, 2022 was $-112.57, a 447.65% decline year-over-year.
  • Bio-Rad Laboratories EPS for the twelve months ending March 31, 2022 was $-4.39, a 103.23% decline year-over-year.
  • Bio-Rad Laboratories 2021 annual EPS was $140.56, a 11.38% increase from 2020.
  • Bio-Rad Laboratories 2020 annual EPS was $126.2, a 116.58% increase from 2019.
  • Bio-Rad Laboratories 2019 annual EPS was $58.27, a 381.57% increase from 2018.
Bio-Rad Laboratories Annual EPS
2021 $140.56
2020 $126.20
2019 $58.27
2018 $12.10
2017 $4.07
2016 $0.88
2015 $3.71
2014 $3.05
2013 $2.69
2012 $5.78
2011 $6.29
2010 $6.59
2009 $5.20
Bio-Rad Laboratories Quarterly EPS
2022-03-31 $-112.57
2021-12-31 $-52.10
2021-09-30 $129.96
2021-06-30 $30.32
2021-03-31 $32.38
2020-12-31 $27.69
2020-09-30 $43.64
2020-06-30 $32.15
2020-03-31 $22.72
2019-12-31 $18.35
2019-09-30 $-8.68
2019-06-30 $19.86
2019-03-31 $28.74
2018-12-31 $-27.43
2018-09-30 $8.89
2018-06-30 $8.87
2018-03-31 $21.77
2017-12-31 $2.76
2017-09-30 $0.73
2017-06-30 $0.17
2017-03-31 $0.41
2016-12-31 $-0.77
2016-09-30 $0.62
2016-06-30 $0.61
2016-03-31 $0.42
2015-12-31 $1.54
2015-09-30 $0.59
2015-06-30 $0.97
2015-03-31 $0.61
2014-12-31 $1.34
2014-09-30 $0.39
2014-06-30 $1.09
2014-03-31 $0.23
2013-12-31 $1.04
2013-09-30 $-0.25
2013-06-30 $1.20
2013-03-31 $0.70
2012-12-31 $1.51
2012-09-30 $1.49
2012-06-30 $1.69
2012-03-31 $1.09
2011-12-31 $2.11
2011-09-30 $1.61
2011-06-30 $1.41
2011-03-31 $1.16
2010-12-31 $2.41
2010-09-30 $1.59
2010-06-30 $1.35
2010-03-31 $1.24
2009-12-31 $1.35
2009-09-30 $1.38
2009-06-30 $1.37
2009-03-31 $1.10
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $15.121B $2.923B
BIO-RAD LABORATORIES, INC. manufactures and supplies to life sciences research, healthcare, analytical chemistry, semiconductor and other markets a broad range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $165.194B 10.05
QIAGEN (QGEN) Netherlands $10.361B 16.35
Biohaven Pharmaceutical Holding (BHVN) United States $10.098B 0.00
Ginkgo Bioworks Holdings (DNA) United States $5.208B 0.00
Emergent Biosolutions (EBS) United States $1.617B 6.92
Arcus Biosciences (RCUS) United States $1.305B 33.09
Myovant Sciences (MYOV) United Kingdom $0.956B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.500B 0.00
Zymeworks (ZYME) Canada $0.368B 0.00
Gelesis Holdings (GLS) United States $0.349B 0.00
Ambrx Biopharma (AMAM) United States $0.154B 0.00
Enzo Biochem (ENZ) United States $0.108B 22.10
SQZ Biotechnologies (SQZ) United States $0.097B 0.00